Alternative Investment Instruments
Conversion of Convertible Loan Notes | 07-Nov-2024 | 07:00 | RNS |
Interim Results to 30 June 2024 | 27-Sep-2024 | 07:00 | RNS |
Grant of Japan MK Cell Patent | 23-Sep-2024 | 07:00 | RNS |
STAT-6 siRNA Demonstrates Efficacy in Immunology | 19-Sep-2024 | 07:00 | RNS |
Grant of MK Cell Patent & Licencing Update | 02-Sep-2024 | 07:00 | RNS |
Results of AGM | 27-Jun-2024 | 12:46 | RNS |
Appointment of Broker | 20-Jun-2024 | 07:00 | RNS |
Notice of Annual General Meeting | 04-Jun-2024 | 07:00 | RNS |
Issue of Convertible Loan Notes & Board Changes | 23-May-2024 | 07:05 | RNS |
Midkine Antibody Licencing Deal | 23-May-2024 | 07:00 | RNS |
Annual Report & Financial Statements - 31 Dec 2023 | 26-Apr-2024 | 07:00 | RNS |
Response to Share Price Movement | 05-Apr-2024 | 07:00 | RNS |
Positive Results: Midkine mRNA and STAT-6 siRNA | 11-Mar-2024 | 07:00 | RNS |
Operations Update | 06-Feb-2024 | 07:00 | RNS |
Change of Auditor | 24-Nov-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 3.80p |
Change Today | -0.50p |
% Change | -11.63 % |
52 Week High | 9.25 |
52 Week Low | 3.35 |
Volume | 3,429,708 |
Shares Issued | 135.74m |
Market Cap | £5.16m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:40 | 6,820 @ 3.80p |
16:40 | 6,820 @ 3.80p |
16:09 | 123,000 @ 4.44p |
15:02 | 250,000 @ 4.32p |
14:56 | 250,000 @ 4.30p |
You are here: research